GCG and GCGR-related hyperglucagonemia: Remarkably, α cell hyperplasia associated with inhibition of glucagon signaling is mostly reversible within 2 months after the inhibition is removed [11], [41], [42], suggesting a possible therapeutic window of opportunity for patients with Mahvash disease at the hyperplastic stage.